Effects of luseogliflozin, a sodium–glucose co‐transporter 2 inhibitor, on 24‐h glucose variability assessed by continuous glucose monitoring in Japanese patients with type 2 diabetes mellitus: a randomized, double‐blind, placebo‐controlled, crossover study

The aim of the present study was to determine the effects of luseogliflozin on 24‐h glucose levels, assessed by continuous glucose monitoring, and on pharmacodynamic variables measured throughout the day. In this double‐blind, placebo‐controlled, crossover study, 37 patients with type 2 diabetes mel...

Full description

Saved in:
Bibliographic Details
Published in:Diabetes Obes Metab
Main Authors: Nishimura, R., Osonoi, T., Kanada, S., Jinnouchi, H., Sugio, K., Omiya, H., Ubukata, M., Sakai, S., Samukawa, Y.
Format: Artigo
Language:Inglês
Published: Blackwell Publishing Ltd 2015
Subjects:
Research Letters
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5032984/
https://ncbi.nlm.nih.gov/pubmed/25930989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12481
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items